Generic Name and Formulations:
Ipratropium bromide 18mcg, albuterol (as sulfate) 90mcg; per inh; metered dose inhaler.
Company:
Boehringer Ingelheim Pharmaceuticals
COPD when a second aerosol bronchodilator is needed.
2 inh 4 times daily; max 12 inh/day.
Not recommended.
Anticholinergic + beta-2 agonist.
Atropine, soybean, soya lecithin, peanut, or related allergy.
Avoid excessive use. Cardiac disease and arrhythmias. Hypertension. Diabetes. Hyperthyroidism. Seizure disorders. Narrow angle glaucoma. GI or GU obstruction. Hepatic or renal disease. Pregnancy (Cat.C). Labor & delivery. Nursing mothers: not recommended.
Extreme caution within 2 weeks of MAOIs or tricyclic antidepressants (increased cardiovascular effects). Caution with other anticholinergics, sympathomimetics, drugs that lower serum potassium. Antagonized by β-blockers.
Bronchitis, upper respiratory tract infection, headache, dyspnea, respiratory disorder, cough, nausea, pain, sinusitis, pharyngitis, influenza, pneumonia, rhinitis, hypertension, dizziness, arrhythmias, nervousness, paradoxical bronchospasm, anaphylaxis.
Inhaler—14.7 g (200 inh)